[Event Report] HGPI-GCOA Joint Roundtable: Vaccine Policies Within the G20 Global Health Agenda (June 5, 2019)
date : 6/24/2019
Tags: Global Health, Vaccinations
Health and Global Policy Institute (HGPI) and Global Coalition on Aging (GCOA) conducted a Joint Roundtable meeting to discuss Adult Vaccine Policies and their value for healthy ageing, preparations for the Decade of Healthy Ageing, and prevention strategies. Adult vaccine policy is a critical driver of prevention and sustainable healthcare systems, and such policies require cross-disciplinary, global collaborations.
With anti-vaccine sentiment growing around the world, there is now great need to strengthen multi-sector collaboration on policies promoting vaccination. Vaccines are an important aspect of preventative medicine. They can help bolster the sustainability of universal health coverage systems by ensuring that populations remain healthy. Vaccines for adults can prevent infectious diseases that disproportionally impact the health older people, thereby encouraging healthy aging. Vaccines also help to strengthen global health security by preventing the spread of infectious diseases between populations. For these reasons, we believe that the G20 should recognize vaccine-for-all policies as a key element of the 21st-century global health agenda.
To that end, we invited experts from various sectors to share their insights on moving vaccine policies forward and positioning vaccine policies within the global health agenda of the G20 and the WHO Decade of Healthy Ageing.
■Overview
Date and time: Wednesday, June 5, 2019, 14:00-15:30
Venue: Nikkei Head Office
Organizer: Health and Global Policy Institute (HGPI) & Global Coalition on Aging (GCOA)
Participants: Experts from various sectors
■Program
Opening Remarks
Michael W. Hodin (CEO, Global Coalition on Aging)
Ryoji Noritake (CEO, Board Member, Health and Global Policy Institute)
Roundtable Discussion
Roundtable Speakers (alphabetical order by last name):
Kyoko Ama (Representative, Ippan Shadan Hojin Shiro Shoni Iryo Mamoro Kodomo-tachi no Kai)
Akihisa Harada (President, Pfizer Japan)
Sayaka Itoh (Principal Researcher, Center for Innovation Policy, Kanagawa University of Human Services)
Surya Kolluri (Managing Director, RPWS Office of Thought Leadership, Bank of America Merrill Lynch)
Christopher LaFleur (Chairman, American Chamber of Commerce in Japan (ACCJ))
Mike Mansfield (Program Director, Aegon Center for Longevity and Retirement, Aegon)
Jonathan Selib (Senior Vice President, Global Policy, Pfizer)
Atsunobu Takeshita (Director, Global Business Division / Nikkei Staff Writer)
Facilitators:
Michael W. Hodin (CEO, Global Coalition on Aging)
Ryoji Noritake (CEO, Board Member, Health and Global Policy Institute)
Matt McEnany (Manager, Health and Global Policy Institute)

Top Research & Recommendations Posts
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Recommendations on Strategic Investments in Policies for Brain Health to Revitalize Japan: Hopes for the New Administration (December 1, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Announcement] HGPI Endorses the “Belém Health Action Plan” (November 14, 2025)
- [Announcement] HGPI Joins Global Green and Healthy Hospitals (August 1, 2023)
- [Research Report] AMR Policy Update #2: WHO’s First Report on Fungal Infection—Bridging the Gap Between Clinical Practice and R&D
Featured Posts
-
2025-12-09
[Event Report] Special Seminar “Rising to New Challenges in Health Sciences for Future Society: Novel Developments in the Field of Epilepsy in Japan and Globally” Belgium Pavilion Special Seminar, World Expo 2025 Osaka, Kansai (September 18, 2025)
-
2025-12-11
[Event Report] Core Components of Universal Health Coverage (UHC): Achieving “Healthcare Without Financial Hardship” in Asia-Pacific and Japan (December 5, 2025)
-
2025-12-12
[Registration Open] Meaningful Involvement Promotion Project Urgent Symposium “The New Takaichi Administration and Central Social Insurance Medical Council Reform – Ensuring Patients’ Voices are Heard” (January 22, 2026)
-
2025-12-12
[Registration Open] (Webinar) The 140th HGPI Seminar “Early Detection to Reduce COPD Disease Burden: Connecting Clinical Frontiers with Health Policy” (January 27, 2026)
-
2025-12-16
[Discussion Points] Policy Dialogue “Considering Comprehensive Genomic Profiling from the Perspective of Patient Access: Utilizing the Medical Service Fee Reimbursement System and the Mixed Medical Services Program to Meet the Needs of Today” (November 28, 2025)



